Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2018

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

2017 Completed Clinical Trials Webinar Banner

Join the Completed Clinical Trials Webinar: Status Quo or No?

Digital Health: Healthcare is transforming... Are you ready?

Find out more

Brexit Implications For Pharma

Learn more

Buy 5 reports for the price of 3!

Discover more

The first-ever Medtech Insight Awards are coming!

Enter now

Welcome to your Pharma Intelligence advantage

Market intelligence

We’re the world’s leading provider of drug, device, company, clinical trial and market intelligence in the competitive pharma and medtech markets.

News and insight

We provide unrivalled and daily-updated global insight, drawn from extensive authoritative data sets and enriched by human validation.

Data and analytics

Our premium quality data is drawn from 42,000 companies, 248,000 clinical trials in 175 countries and 65,000 drugs for 1,400 diseases.

Consultancy

Our bespoke clinical, commercial and market access solutions are designed to help you make smarter decisions that bring a better return on investment.

Global industry experts

Working in an interconnected global network, our 65 journalists and over 300 in-house analysts supply comprehensive analysis and reports.

Trusted partnerships

We’re the trusted partner of more than 3,000 companies including the top 50 pharma firms and top 10 contract research organizations.

Gold-standard service

Our customer services team will support you every step of the way so that our insight, intelligence and bespoke solutions match your needs.

Tailor-made solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round your exact needs.

Our Specialties

Clinical trial intelligence

Gain a competitive edge with comprehensive clinical trial intelligence. Find out what competitors are doing in key areas, understand regulations, view clinical trial and program timelines, identify sites and investigators.

Competitive and market intelligence

See the entire global biopharma and medtech market landscape in one place – our expert analysis and trusted databases cover all sectors of the industry.

business development licensing pharma intelligence

Business development and licensing

Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.

business portfolio strategy pharma intelligence

Pharmaceutical portfolio strategy

Identify M&A targets and partnership opportunities, and develop business cases with our real-time intelligence, tools and analysis.

Regulatory approval

An increasingly complex regulatory framework for the pharmaceutical, biotech and medtech industries presents growing challenges to businesses. We’ll help you stay ahead.

medtech competitive intelligence pharma intelligence

Medtech market intelligence

To succeed in medtech, you need to have your finger on the pulse – we’ll help you access the accurate, reliable information you need.

View more
View Less

Our trusted Pharma Intelligence brands

Scrip

Eisai's Obesity Drug Belviq Passes Cardiovascular Outcomes Test

By Emily Hayes 18 Jul 2018

The Japanese pharma says it will discuss the data with US FDA, with hopes of potential to incorporate secondary endpoint data in labeling.

Topic Obesity Clinical trials

View article
Scrip

As J&J Sees Continued Drug Price Declines, CEO Urges Slow Policy Change Via Trump's Blueprint

By Jessica Merrill 18 Jul 2018

J&J told investors to anticipate negative net drug pricing of 4%-6% across its portfolio in 2018, following a 4.6% negative impact in 2017. CEO Alex Gorsky also cautioned against changing drug pricing policy too quickly.

Topic Policy and regulation

View article
Medtech Insight

Open Payments: Zimmer, Medtronic Top List Of Spenders

By Elizabeth Orr 17 Jul 2018

Major medical device companies paid almost $1bn in consulting fees, royalties, research costs and other expenses to physicians in 2017, the most recent data release from the US Open Payments database shows. Zimmer Biomet reported the highest spending on general physician payments, while Roche and Medtronic topped the list of research spending.

Topic Clinical trials

View article
Medtech Insight

Compliance Corner: Follow These 4 Tips From FDA's Maisel For A Better Pre-Market Experience

By Shawn M. Schmitt 17 Jul 2018

Bill Maisel – the director of the Office of Device Evaluation within US FDA's Center for Devices and Radiological Health (among other titles) – says there are four things device-makers should do to make sure they succeed during the product-review process.

Topic Business strategies

View article
Pink Sheet

Express Scripts Pushing Manufacturers To Lower List Prices By Offering Cheaper Brand Alternatives

By Cathy Kelly 16 Jul 2018

Companies should introduce same drug under new NDC at lower list price to overcome difficulties of reducing list prices on existing brands, PBM says.

Topic Policy and regulation

View article
Pink Sheet

Long-Awaited Brexit White Paper Lays Out UK's Plans For Medicines Regulation

By Francesca Bruce 16 Jul 2018

The UK government has finally published its white paper on the UK’s future relationship with the EU following Brexit, to the relief of the pharmaceutical industry.

Topic Brexit

View article
Pharmaprojects

Microbiome Modulators for Gastrointestinal Disorders In 2018: Market Overview & The Current Phase I Candidates

13 Jul 2018

The discovery and deep investigation of the microbiome has been one of the most significant recent biomedical advances. Extensive research suggests that dysbiosis of the gut microbiome plays a significant role in multiple gastrointestinal (GI) disorders such as; Crohn’s disease, ulcerative colitis, and irritable bowel syndrome (IBS).

Single report
Pharmaprojects

2018 R&D Review: 5 Key Takeaways

13 Jul 2018

Welcome to Pharmaprojects’ roundup of key trends in pharmaceutical R&D in 2018, focusing on five key takeaways from our full annual report

Single report
Scrip

Authorities Find Accounting Violation By Samsung BioLogics, Prosecutors To Probe

By Jung Won Shin 13 Jul 2018

South Korean financial authorities conclude Samsung BioLogics violated accounting standards by omitting certain information on its joint venture agreement with Biogen from public disclosures, and have ordered further investigation of a corporate governance decision on the handling in accounts of the JV, Samsung Bioepis. The latest ruling in the prolonged affair could hurt the credibility and business of Samsung BioLogics going forward, although the firm maintains it has done nothing improper.

Topic Policy and regulation

View article
Scrip

Mylan's Fulphila Sets Up The US Market For The Next Biosimilar Showdown

By Jessica Merrill 13 Jul 2018

Mylan has priced its biosimilar version of pegfilgrastim at a 33% discount to Amgen's WAC for Neulasta, steeper than the 15% discount Pfizer initially offered for Inflectra. The commercial outcome for Fulphila could set the tone for future US biosimilars, which have yet to take off.

Topic Biosimilars Business strategies

View article
In Vivo

Cancer Vaccines: Is There A Future Beyond Trial And Error?

By William Looney 12 Jul 2018

Strong foundational research in immunology and some promising early phase trial results have so far failed to expedite the validation of vaccines to treat cancer. In Vivo examines biopharma’s enduring optimism about the future of cancer vaccinology, including a closer look at one company’s platform to tackle the incurable malignancies that beset the mother of all organs: the human brain.

Topic Cancer Vaccines

View article
Rose Sheet

Hawaii's Sunscreen Ingredient Ban Is On The Books; To Industry, An Affront To Science

By Lauren Nardella 12 Jul 2018

As in the case of plastic microbeads some four years ago, the personal-care industry finds itself in the position of having to reformulate potentially on a mass scale due to environmental rather than human safety concerns. And once again the legislation was driven in large part by shoddy science, industry says.

Topic Policy and regulation

View article
Rose Sheet

EU Watch: Next Steps Re Controversial CMR Ban Approach, Fragrance Allergens Labeling

By Ryan Nelson 12 Jul 2018

EU sources update Rose Sheet on contentious initiatives to cement the Commission’s pathway for banning carcinogenic, mutagenic or reprotoxic substances in cosmetics and to promote fragrance allergen awareness and risk management.

Topic Policy and regulation

View article
Scrip

Downward, Eastward or Inward? Blockbuster Film Puts Cancer Drug Prices In China Spotlight

By Brian Yang 11 Jul 2018

Bagging a $200m box office in its opening week in China, "Dying to Survive" is a sentimental movie about a Chinese businessman selling cancer drugs smuggled from India but unapproved in China that sees his life taking a drastic turn, from convicted felon to a Robin Hood-like hero as he helps those in need. The Chinese film authority’s clearance for the screening of the movie and the smash success signal three key messages about the future potential direction of oncology drugs in the country.

Topic Cancer

View article
Scrip

Pfizer Agrees To Roll Back Prices On 40 Drugs, Yielding To Pressure From Trump

By Jessica Merrill 11 Jul 2018

After a conversation with President Trump, CEO Ian Read agreed to cancel price increases on 40 drugs that took effect July 1, to give the administration time to work on its blueprint for improving the health care system.

Topic Policy and regulation

View article

Latest headlines

Scrip

18 Jul 2018

Profile: Lupin CFO Swaminathan, The ‘Constant Learner'

Link
Medtech Insight

18 Jul 2018

Diabetes Firm CeQur Gains J&J's Calibra Wearable Insulin Patch

Link
Medtech Insight

18 Jul 2018

Exec Chat: KCI CEO Andrew Eckert Forsees Big Year For Wound-Care Company

Link
Medtech Insight

18 Jul 2018

Switzerland Overhauls Export Certificate Application System

Link
Medtech Insight

18 Jul 2018

FDA Panel To Ponder Down-Classifying HIV Tests

Link
Medtech Insight

18 Jul 2018

Nevro May Lose Pain-Stim Patent Case Against Boston Scientific

Link
Scrip

18 Jul 2018

Korea Eyes New Consortium To Support Innovation, Nurture Biotech Hubs

Link
In Vivo

18 Jul 2018

Deals Shaping The Medical Industry, July 2018

Link
Scrip

18 Jul 2018

Pfizer/Lilly's Tanezumab Reduces Osteoarthritis Pain, But Is It Safe?

Link
Medtech Insight

18 Jul 2018

Medtech Suppliers Still Out Of Pocket As Turkish Hospital Debt Trundles On

Link
Scrip

18 Jul 2018

J&J’s Symtuza Approved, But Commercial Outlook Uncertain

Link
Medtech Insight

18 Jul 2018

Data Control Key In Applying Electronic Health Records As Clinical Trial Tool, FDA Says

Link
Pink Sheet

18 Jul 2018

Novartis Puts A Halt To Drug Price Increases While Awaiting More On Trump's Blueprint

Link
Medtech Insight

18 Jul 2018

CMS To Remove Quality Measures For Breast Cancer Biopsies, Some CABG Procedures And More

Link
Pink Sheet

18 Jul 2018

Industry Urged To Watch And Wait For US/China Tariff War To Blow Over

Link

Featured products

Trialtrove: gold standard clinical trials intelligence

Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.

Key benefits:

Curated by experts
Clinical trial landscape view
Standard of care insights

Datamonitor Healthcare: data analysis and insight

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

Key benefits:

Prioritize market opportunities
Identify unmet needs
Make informed decisions

Scrip: industry news and insights

Key benefits:

Follow market developments
Go beyond the news
Hear from news makers

Upcoming events

USA

Awards

Medtech Insight Awards 2018 in Partnership with The MedTech Conference

Spain

Awards

Global Generics & Biosimilars Awards 2018

Awards

Scrip Awards 2018

View All Events

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Join the Completed Clinical Trials Webinar: Status Quo or No?

Digital Health: Healthcare is transforming... Are you ready?

Brexit Implications For Pharma

Buy 5 reports for the price of 3!

The first-ever Medtech Insight Awards are coming!

Welcome to your Pharma Intelligence advantage

Below are the Feature List

Market intelligence

News and insight

Data and analytics

Consultancy

Global industry experts

Trusted partnerships

Gold-standard service

Tailor-made solutions

Our Specialties

Pharma Intelligence latest insights

Latest headlines

Featured products

Below are the Product Brand List

Trialtrove: gold standard clinical trials intelligence

Datamonitor Healthcare: data analysis and insight

Scrip: industry news and insights

Upcoming events

Medtech Insight Awards 2018 in Partnership with The MedTech Conference

Global Generics & Biosimilars Awards 2018

Scrip Awards 2018

Keep up to date

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store